NCT01946126已完成不适用
A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Allergan
- 入组人数
- 459
- 主要终点
- Presence or Absence of Prophylactic Medication for Headache/Migraine
研究概览
简要总结
This study is a retrospective chart review in patients diagnosed with headache or migraine to evaluate treatment patterns and diagnosis.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of chronic migraine or other diagnosis of migraine or headache for a minimum of 15 months
- •Eight (8) headache days per month for at least 1 of the preceding 15 months
排除标准
- •Not currently diagnosed with chronic migraine, headache or migraine
- •History of receiving botulinum toxin injections for the treatment of chronic migraine.
结局指标
主要结局
Presence or Absence of Prophylactic Medication for Headache/Migraine
时间窗: 15 Months
The presence or absence of prophylactic medications used by the subject for headache/migraine is evaluated through the study period.
次要结局
- Number of Visits for Headache Diagnosis(15 Months)
- Highest Number of Headache Days Per Month at a Qualifying Visit(15 Months)
- Number of Unique Prophylactic Medications for Headache/Migraine Reported(15 Months)
- Number of Days With a Headache Recorded at the Visit With the Highest Number of Headaches(15 Months)
研究者
相似试验
已完成
不适用
A Retrospective Chart Review Study to Evaluate Safety of McGhan Single Lumen Gel-Filled Breast Implants in Patients in ChinaBreast AugmentationBreast ReconstructionNCT04261608Allergan225
已完成
不适用
Clinical Outcome of Triheptanoin Treatment in Patients With Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) Treated Under Expanded Access ProgramLong-chain Fatty Acid Oxidation Disorders (LC-FAOD)NCT03768817Ultragenyx Pharmaceutical Inc20
已完成
不适用
A Retrospective Chart Review Study of the Outcomes of 2nd Line Therapy With LEn/Dex in Greek Patients With R/R Multiple MyEloma and the Treatment PatterNs Following Progressive DiseaseRelapsed/Refractory Multiple MyelomaNCT02608515Genesis Pharma S.A.207
已完成
不适用
A Retrospective Non-Interventional Study to Evaluate the Impact of Eculizumab in Korean PNH PatientsPNHNCT05337683Handok Inc.80
已完成
不适用
Retrospective Chart Review Study of Patients With PIK3CA-Related Overgrowth Spectrum Who Have Received AlpelisibPIK3CA-Related Overgrowth Spectrum (PROS)NCT04285723Novartis Pharmaceuticals57